Additionally, NKCC1 and KCC2 have been implicated in a range of neurological diseases beyond epilepsy, including Down syndrome, Parkinson's disease, Alzheimer's, Huntington's disease, and neuropsychiatric disorders such as schizophrenia (18). Here, SLC12A2 is linked to epilepsy.